Yanlin Li

发表

Effects of percutaneous aortic valve replacement on coronary blood flow assessed with transesophageal Doppler echocardiography in patients with severe aortic stenosis.

K. Kent, A. Pichard, L. Satler, 2009, The American journal of cardiology.

Clinical profile, prognostic implication, and response to treatment of pulmonary hypertension in patients with severe aortic stenosis.

S. Epstein, K. Kent, A. Pichard, 2011, The American journal of cardiology.

Value of blood transfusion in patients with a blood hematocrit of 24% to 30% after percutaneous coronary intervention.

G. Lemesle, K. Kent, A. Pichard, 2009, The American journal of cardiology.

Outcomes in diabetic versus nondiabetic patients who present with acute myocardial infarction and are treated with drug-eluting stents.

K. Kent, A. Pichard, L. Satler, 2010, The American journal of cardiology.

Clinical profile, treatment assignment and clinical outcome of patients with severe aortic stenosis not eligible to participate in a clinical trial of percutaneous aortic valve replacement.

G. Lemesle, K. Kent, A. Pichard, 2010, The American journal of cardiology.

Correlates and Causes of Death in Patients With Severe Symptomatic Aortic Stenosis Who Are Not Eligible to Participate in a Clinical Trial of Transcatheter Aortic Valve Implantation

K. Kent, A. Pichard, L. Satler, 2010, Circulation.

Utility of radiologic review for noncardiac findings on multislice computed tomography in patients with severe aortic stenosis evaluated for transcatheter aortic valve implantation.

K. Kent, A. Pichard, L. Satler, 2010, The American journal of cardiology.

Response to Letters Regarding Article, “Does Black Ethnicity Influence the Development of Stent Thrombosis in the Drug-Eluting Stent Era?”

G. Lemesle, K. Kent, A. Pichard, 2011 .

Outcomes in patients with intra-aortic balloon pump who met the same inclusion criteria in the PROTECT II (a prospective feasibility trial investigating the use of the impella recover LP 2.5 system in patients undergoing high risk percutaneous coronary intervention) Study

G. Lemesle, K. Kent, A. Pichard, 2009 .

Prophylactic use of intra-aortic balloon pump for high-risk percutaneous coronary intervention: will the Impella LP 2.5 device show superiority in a clinical randomized study?

G. Lemesle, K. Kent, A. Pichard, 2010, Cardiovascular revascularization medicine : including molecular interventions.

COMPLICATIONS AND OUTCOMES OF BALLOON AORTIC VALVULOPLASTY IN HIGH-RISK OR INOPERABLE PATIENTS

K. Kent, A. Pichard, L. Satler, 2010 .

Incidence, correlates, and clinical impact of nuisance bleeding after antiplatelet therapy for patients with drug-eluting stents.

K. Kent, A. Pichard, L. Satler, 2010, American heart journal.

Hybrid strategy of a bare metal stent combined with a drug-eluting stent versus exclusive drug-eluting stent implantation for multivessel percutaneous coronary intervention.

K. Kent, A. Pichard, L. Satler, 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

The safety and effectiveness comparison of Delta Medical's PEEK interface screw and Endobutton and that of Smith & Nephew's in arthroscopic anterior cruciate ligament reconstruction: A multicenter prospective double-blind randomized controlled clinical trial

M. Yuan, Yanlin Li, Jing Wang, 2022, Frontiers in Public Health.

A further word of caution before using the internal mammary artery for coronary revascularization in patients with severe peripheral vascular disease!

K. Kent, A. Pichard, L. Satler, 2010, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Does Black Ethnicity Influence the Development of Stent Thrombosis in the Drug-Eluting Stent Era?

G. Lemesle, K. Kent, A. Pichard, 2010, Circulation.

Effect of drug-eluting stents on frequency of repeat revascularization in patients with unstable angina pectoris or non-ST-elevation myocardial infarction.

G. Lemesle, K. Kent, A. Pichard, 2009, The American journal of cardiology.

Efficacy and Safety of Transcatheter vs. Surgical Aortic Valve Replacement in Low-to-Intermediate-Risk Patients: A Meta-Analysis

Z. Xi, Wei Liu, Yu-jie Zhou, 2020, Frontiers in Cardiovascular Medicine.

Erratum to “Prophylactic use of intra-aortic balloon pump for high-risk percutaneous coronary intervention: will the Impella LP 2.5 device show superiority in a clinical randomized study?" (Cardiovasc Revasc Med 2010;11(2):91–7)

G. Lemesle, K. Kent, A. Pichard, 2011 .

TRANSCATHETER AORTIC VALVE IMPLANTATION UNDER CONSCIOUS SEDATION VERSUS GENERAL ANESTHESIA WITH INTUBATION

K. Kent, A. Pichard, L. Satler, 2010 .

Value of blood transfusion in patients with a blood hematocrit of 24% to 30% after percutaneous coronary intervention.

G. Lemesle, K. Kent, A. Pichard, 2009, The American journal of cardiology.